Publications Office of the EU
"Supply of the medicinal product Jardiance 10 mg, for a project financed by the Medical Research Agency, Poland, Project No 2020/ABM/01/00001, entitled: ‘Administration of empagliflozin in patients with hypertrophic cardiomyopathy’ and study support for repackaging, labelling, placebo formulation, site delivery and disposal of the investigational medicinal product and placebo.’ - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

"Supply of the medicinal product Jardiance 10 mg, for a project financed by the Medical Research Agency, Poland, Project No 2020/ABM/01/00001, entitled: ‘Administration of empagliflozin in patients with hypertrophic cardiomyopathy’ and study support for repackaging, labelling, placebo formulation, site delivery and disposal of the investigational medicinal product and placebo.’ Text automatically translated in your browsing language Automatically translated

  • Published
    05/05/2025
  • Deadline
    04/06/2025
  • Opening of tenders
    04/06/2025
  • Today
    23/06/2025
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego - Państwowy Instytut Badawczy
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL911 Miasto Warszawa
Business sector (Main CPV)
98300000 Miscellaneous services
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
2
Tender reference number
ZP.037.2025
Description

"Supply of the medicinal product Jardiance 10 mg, for a project financed by the Medical Research Agency, Poland, Project No 2020/ABM/01/00001, entitled: ‘Application of empagliflozin in patients with hypertrophic cardiomyopathy’ and study support for repackaging, labelling, placebo formulation, site delivery and disposal of the investigational medicinal product and placebo’ Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://ikard.ezamawiajacy.pl/pn/ikard/demand/207796/notice/public/details
Tenders may be submitted
Electronic submission: required
https://ikard.ezamawiajacy.pl/pn/ikard/demand/207796/notice/public/details
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
04/06/2025 13:00
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.